Unknown

Dataset Information

0

Cost-Effectiveness Analysis of a Capitated Patient Navigation Program for Medicare Beneficiaries with Lung Cancer.


ABSTRACT: To assess the cost-effectiveness of implementing a patient navigation (PN) program with capitated payment for Medicare beneficiaries diagnosed with lung cancer.Cost-effectiveness analysis.A Markov model to capture the disease progression of lung cancer and characterize clinical benefits of PN services as timeliness of treatment and care coordination. Taking a payer's perspective, we estimated the lifetime costs, life years (LYs), and quality-adjusted life years (QALYs) and addressed uncertainties in one-way and probabilistic sensitivity analyses.Model inputs were extracted from the literature, supplemented with data from a Centers for Medicare and Medicaid Services demonstration project.Compared to usual care, PN services incurred higher costs but also yielded better outcomes. The incremental cost and effectiveness was $9,145 and 0.47 QALYs, respectively, resulting in an incremental cost-effectiveness ratio of $19,312/QALY. One-way sensitivity analysis indicated that findings were most sensitive to a parameter capturing PN survival benefit for local-stage patients. CE-acceptability curve showed the probability that the PN program was cost-effective was 0.80 and 0.91 at a societal willingness-to-pay of $50,000 and $100,000/QALY, respectively.Instituting a capitated PN program is cost-effective for lung cancer patients in Medicare. Future research should evaluate whether the same conclusion holds in other cancers.

SUBMITTER: Shih YC 

PROVIDER: S-EPMC4799903 | biostudies-other | 2016 Apr

REPOSITORIES: biostudies-other

altmetric image

Publications

Cost-Effectiveness Analysis of a Capitated Patient Navigation Program for Medicare Beneficiaries with Lung Cancer.

Shih Ya-Chen Tina YC   Chien Chun-Ru CR   Moguel Rocio R   Hernandez Mike M   Hajek Richard A RA   Jones Lovell A LA  

Health services research 20150626 2


<h4>Objective</h4>To assess the cost-effectiveness of implementing a patient navigation (PN) program with capitated payment for Medicare beneficiaries diagnosed with lung cancer.<h4>Data sources/study setting</h4>Cost-effectiveness analysis.<h4>Study design</h4>A Markov model to capture the disease progression of lung cancer and characterize clinical benefits of PN services as timeliness of treatment and care coordination. Taking a payer's perspective, we estimated the lifetime costs, life years  ...[more]

Similar Datasets

| S-EPMC4700012 | biostudies-literature
| S-EPMC6726189 | biostudies-literature
| S-EPMC7921898 | biostudies-literature
| S-EPMC4072900 | biostudies-literature
| S-EPMC7736121 | biostudies-literature
| S-EPMC4722219 | biostudies-literature
| S-EPMC8008697 | biostudies-literature
| S-EPMC8519430 | biostudies-literature
| S-EPMC9454930 | biostudies-literature
| S-EPMC6232439 | biostudies-literature